Mortality in women given diethylstilbestrol during pregnancy

British Journal of Cancer

Volumn 95, Issue 1, 2006, Pages 107-111

  Titus Ernstoff, L ^a   Troisi, R ^a,b   Hatch, E E ^c   Palmer, J R ^d   Wise, L A ^d   Ricker, W ^e   Hyer, M ^e   Kaufman, R ^f   Noller, K ^g   Strohsnitter, W ^g   Herbst, A L ^h   Hartge, P ^b   Hoover, R N ^b  

^a NORRIS COTTON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BOSTON UNIVERSITY   (United States)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

^f HOUSTON METHODIST HOSPITAL   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

Author keywords

Breast cancer; DES; Mortality; Oestrogens

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CAUSE OF DEATH; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; DRUG MEGADOSE; FEMALE; GYNECOLOGIC CANCER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; CAUSE OF DEATH; COHORT STUDIES; DIETHYLSTILBESTROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MORTALITY; ODDS RATIO; PREGNANCY; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; UNITED STATES;

EID: 33745573271     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603221     Document Type: Article

References (23)

1. Autunes CMF, Stolley PD, Rosenshein NB, Davies JL, Tonascia JA, Brown C, Burnett L, Rutledge A, Pokempner M, Garcia R (1979) Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med 300: 9-13
2. Beral V, Colwell L (1980) Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long term follow-up of mothers. BMJ 281: 1098-1101
3. Bibbo M, Haenszel WM, Wied GL, Hubby M, Herbst AL (1978) A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med 298: 763-767
4. Calle EE, Mervis CA, Thun MJ, Rodriguez C, Wingo PA, Heath Jr CW (1996) Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol 144: 645-652
5. Clark LG, Portier KM (1979) Diethylstilbestrol and the risk of cancer. N Engl J Med (ltr) 300: 263-264
6. Colton T, Greenberg ER, Noller K, Resseguie L, Van Bennekom C, Heeren T, Zhang Y (1993) Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. J Am Med Assoc 269: 2096-2100
7. Cox DR (1972) Regression models and life tables. J R Stat Soc B 34: 187-220
8. Dieckmann WJ, Davis ME, Rynkiewicz LM, Pottinger RE (1953) Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 66: 1062-1081
9. Greenberg ER, Barnes AB, Resseguie L, Barrett JA, Burnside S, Lanza LL, Neff RK, Stevens M, Young RH, Colton T (1984) Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 311: 1393-1398
10. Hadjimichael OC, Meigs JW, Falcier FW, Thompson WD, Flannery JT (1984) Cancer risk among women exposed to exogenous estrogens during pregnancy. J Natl Cancer Inst 73: 831-834
11. Hart AC (ed) (2000) ICD-9 Code Book. Reston, VA: St Anthony Publishing
12. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284: 878-881
13. Hoover R, Fraumeni Jr JF, Everson R, Myers MH (1976) Cancer of the uterine corpus after hormonal treatment for breast cancer. Lancet 1: 885-887
14. Hoover R, Gray LA, Fraumeni Jr JF (1977) Stilboestrol (Diethylstilbestrol) and the risk of ovarian cancer. Lancet 2: 533-534
15. Newbold RR (1993) Gender-related behavior in women exposed prenatally to diethylstilbestrol. Environ Health Perspect 101: 208-213
16. Noller KL, Fish CR (1974) Diethylstylbestrol usage: its interesting past, important present, and questionable future. Med Clin N Am 58: 793-810
17. Onarglioglu B, Gunay Y, Goze I, Koptagel E (1998) Renal ultrastructural alterations following administration of diethylstilbestrol. Tr J Med Sci 28: 369-374
18. Shumaker SA, Legault C, Kuller L, Rapp SR, Tal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH (2004) Conjugated equine estrogens and incidence of probably dementia and mild cognitive impairment in postmenopausal women. J Am Med Assoc 291: 2947-2958
19. Swyer GIM, Law RG (1954) An evaluation of the prophylactic ante-natal use of stilboestrol. Preliminary report. J Endocrinol 10: vi
20. Titus-Ernstoff L, Hatch EE, Hoover RN, Palmer J, Greenberg ER, Ricker W, Kaufman R, Noller K, Herbst AL, Colton T, Hartge P (2001) Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 84: 126-133
21. Vessey MP, Fairweather DV, Norman-Smith B, Buckley J (1983) A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynecol 90: 1007-1017
22. Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. J Am Med Assoc 291: 1701-1712
23. World Health Organization (2003) ICD-10 Code Book. International Classification of Diseases. US Natl Center Health Stat